CLARITHROMYCIN

CLARITHROMYCIN was reported 34499 times

CLARITHROMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 175 0.5776
1 SALPINGO-OOPHORECTOMY UNILATERAL 33 0.3000
2 MYCOBACTERIAL PERITONITIS 23 0.2421
3 NEUROPSYCHIATRIC LUPUS 25 0.2066
4 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 24 0.1920
5 MYCOBACTERIUM FORTUITUM INFECTION 24 0.1297
6 FEMALE GENITAL TRACT FISTULA 221 0.1293
7 MYCOBACTERIUM CHELONAE INFECTION 91 0.1231
8 MYCOBACTERIUM ABSCESSUS INFECTION 79 0.1105
9 HEPATIC ISCHAEMIA 29 0.0932
10 MYCOBACTERIUM HAEMOPHILUM INFECTION 24 0.0839
11 CHRONIC SINUSITIS 302 0.0804
12 SOFT TISSUE MASS 34 0.0736
13 RADICULOPATHY 182 0.0690
14 MACULAR DEGENERATION 815 0.0682
15 MYCOBACTERIAL INFECTION 115 0.0667
16 ATYPICAL MYCOBACTERIAL INFECTION 93 0.0657
17 PROCTITIS 176 0.0628
18 MYCOBACTERIUM AVIUM COMPLEX INFECTION 166 0.0618
19 SINUSITIS FUNGAL 41 0.0511
20 PATHOGEN RESISTANCE 458 0.0502
21 PNEUMONIA MYCOPLASMAL 39 0.0490
22 TACHYCARDIA FOETAL 24 0.0481
23 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 155 0.0469
24 OTOTOXICITY 86 0.0465
25 OESOPHAGEAL PERFORATION 37 0.0444
26 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 379 0.0428
27 HELICOBACTER GASTRITIS 50 0.0403
28 ENTEROCOLITIS HAEMORRHAGIC 58 0.0392
29 CONTRAINDICATED DRUG ADMINISTERED 27 0.0386
30 SUPERINFECTION 56 0.0373
31 CARDIOACTIVE DRUG LEVEL INCREASED 48 0.0365
32 PRESSURE OF SPEECH 23 0.0354
33 ACUTE PSYCHOSIS 85 0.0343
34 LIP EROSION 23 0.0315
35 PULMONARY CAVITATION 27 0.0310
36 HYPOCOAGULABLE STATE 30 0.0308
37 MYOPERICARDITIS 24 0.0308
38 PSEUDOMEMBRANOUS COLITIS 68 0.0304
39 IMMUNE RECONSTITUTION SYNDROME 39 0.0302
40 LONG QT SYNDROME 72 0.0300
41 LYMPHOCYTE STIMULATION TEST POSITIVE 24 0.0300
42 DIFFUSE ALVEOLAR DAMAGE 33 0.0287
43 PARADOXICAL DRUG REACTION 103 0.0280
44 LUNG CONSOLIDATION 77 0.0275
45 MULTIMORBIDITY 32 0.0267
46 SPUTUM INCREASED 57 0.0263
47 POTENTIATING DRUG INTERACTION 88 0.0262
48 VANISHING BILE DUCT SYNDROME 29 0.0260
49 LABILE BLOOD PRESSURE 29 0.0244
50 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 118 0.0237
51 OPTIC NEUROPATHY 50 0.0236
52 PNEUMATOSIS INTESTINALIS 66 0.0231
53 ORAL CANDIDIASIS 303 0.0230
54 LABELLED DRUG-DRUG INTERACTION ISSUE 33 0.0228
55 LOSS OF EMPLOYMENT 68 0.0225
56 DEAFNESS BILATERAL 38 0.0223
57 FIXED ERUPTION 38 0.0221
58 OESOPHAGEAL SPASM 40 0.0217
59 RENAL ATROPHY 27 0.0216
60 TONGUE DISCOLOURATION 92 0.0210
61 PALATAL OEDEMA 26 0.0210
62 CONTRAINDICATED PRODUCT PRESCRIBED 35 0.0208
63 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 55 0.0207
64 PARAESTHESIA ORAL 297 0.0206
65 OBSTRUCTIVE SLEEP APNOEA SYNDROME 30 0.0206
66 INHIBITORY DRUG INTERACTION 32 0.0202
67 UPPER RESPIRATORY TRACT INFLAMMATION 24 0.0200
68 STENOTROPHOMONAS INFECTION 27 0.0199
69 BRADYARRHYTHMIA 32 0.0195
70 DRUG INTERACTION 3039 0.0191
71 HALLUCINATIONS, MIXED 79 0.0188
72 LIP OEDEMA 78 0.0184
73 TONGUE OEDEMA 70 0.0183
74 VAGINAL DISCHARGE 183 0.0181
75 CYTOMEGALOVIRUS CHORIORETINITIS 35 0.0179
76 MYOSITIS 161 0.0179
77 DEREALISATION 38 0.0176
78 DIASTOLIC DYSFUNCTION 54 0.0175
79 SWOLLEN TONGUE 540 0.0173
80 LEUKOCYTOCLASTIC VASCULITIS 28 0.0172
81 PHARYNGEAL ERYTHEMA 36 0.0170
82 TORSADE DE POINTES 133 0.0169
83 RESPIRATORY SYMPTOM 48 0.0169
84 DRUG LEVEL INCREASED 278 0.0168
85 LYMPHOEDEMA 115 0.0166
86 EOSINOPHILIC PNEUMONIA 51 0.0162
87 DEAFNESS NEUROSENSORY 53 0.0161
88 PNEUMOMEDIASTINUM 29 0.0160
89 HEPATORENAL SYNDROME 27 0.0160
90 EMBOLISM VENOUS 48 0.0158
91 NEPHROGENIC ANAEMIA 71 0.0153
92 RALES 89 0.0153
93 HYPERPARATHYROIDISM SECONDARY 38 0.0152
94 FOETAL DISTRESS SYNDROME 32 0.0151
95 MYOPATHY 130 0.0150
96 BIPOLAR I DISORDER 33 0.0150
97 ERYTHEMA MULTIFORME 139 0.0149
98 MEGACOLON 23 0.0146
99 HEPATITIS FULMINANT 43 0.0145
100 ABDOMINAL WALL HAEMATOMA 28 0.0143
101 TRANSPLANT FAILURE 35 0.0143
102 DRUG RESISTANCE 362 0.0141
103 HYPERACUSIS 52 0.0140
104 DRUG ERUPTION 242 0.0136
105 CLOSTRIDIUM TEST POSITIVE 30 0.0136
106 SKIN INDURATION 28 0.0135
107 PARAPARESIS 24 0.0135
108 OESOPHAGEAL PAIN 53 0.0134
109 MULTIPLE-DRUG RESISTANCE 41 0.0132
110 HELICOBACTER INFECTION 135 0.0131
111 INFLAMMATORY MARKER INCREASED 65 0.0131
112 REBOUND ACID HYPERSECRETION 39 0.0129
113 RHABDOMYOLYSIS 537 0.0129
114 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 26 0.0127
115 PURPURA 112 0.0126
116 BRONCHOPNEUMONIA 42 0.0123
117 TOXIC EPIDERMAL NECROLYSIS 185 0.0122
118 HYPOMANIA 44 0.0120
119 NEPHROPATHY TOXIC 132 0.0117
120 HEPATOSPLENOMEGALY 30 0.0117
121 ANGIOEDEMA 512 0.0116
122 ELECTROCARDIOGRAM QT PROLONGED 412 0.0114
123 NASAL POLYPS 56 0.0114
124 NOSOCOMIAL INFECTION 25 0.0113
125 RETROPERITONEAL HAEMATOMA 25 0.0113
126 LOWER RESPIRATORY TRACT INFECTION 509 0.0112
127 MANIA 184 0.0112
128 CHRONIC GASTRITIS 25 0.0111
129 LIP SWELLING 366 0.0110
130 SLEEP TERROR 46 0.0109
131 HAEMANGIOMA 25 0.0108
132 HEPATITIS CHOLESTATIC 65 0.0108
133 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 24 0.0107
134 HYPERCAPNIA 32 0.0106
135 NOCARDIOSIS 27 0.0105
136 MOUTH SWELLING 60 0.0104
137 INTERNATIONAL NORMALISED RATIO INCREASED 295 0.0103
138 STEVENS-JOHNSON SYNDROME 228 0.0102
139 BRONCHOPULMONARY ASPERGILLOSIS 78 0.0101
140 DYSGEUSIA 741 0.0100
141 HAEMOLYTIC URAEMIC SYNDROME 23 0.0099
142 CREPITATIONS 29 0.0097
143 PERSECUTORY DELUSION 24 0.0096
144 HEPATIC NECROSIS 36 0.0095
145 CLOSTRIDIUM DIFFICILE COLITIS 101 0.0095
146 ENTEROCOCCAL INFECTION 46 0.0095
147 LYMPHADENITIS 23 0.0095
148 ABDOMINAL TENDERNESS 47 0.0095
149 PLEURITIC PAIN 26 0.0094
150 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 73 0.0094
151 RASH MACULO-PAPULAR 208 0.0093
152 SWELLING FACE 597 0.0092
153 JAUNDICE CHOLESTATIC 32 0.0090
154 HYPOVOLAEMIA 53 0.0090
155 TUBULOINTERSTITIAL NEPHRITIS 169 0.0090
156 COAGULOPATHY 150 0.0090
157 GRANULOMA 31 0.0089
158 PNEUMONIA BACTERIAL 82 0.0089
159 HEPATITIS TOXIC 23 0.0088
160 FORCED EXPIRATORY VOLUME DECREASED 25 0.0088
161 GENERALISED ERYTHEMA 50 0.0088
162 DERMATITIS BULLOUS 63 0.0087
163 DERMATITIS EXFOLIATIVE GENERALISED 30 0.0086
164 BRONCHIECTASIS 58 0.0086
165 PHARYNGEAL SWELLING 84 0.0086
166 ILEUS PARALYTIC 38 0.0085
167 KLEBSIELLA INFECTION 43 0.0085
168 GLOSSITIS 30 0.0084
169 FREQUENT BOWEL MOVEMENTS 228 0.0084
170 PHOTOPSIA 53 0.0084
171 TACHYPHRENIA 29 0.0084
172 HYPOGLYCAEMIC COMA 24 0.0083
173 PROCEDURAL PAIN 231 0.0083
174 RENAL FAILURE ACUTE 353 0.0083
175 DIVERTICULUM 59 0.0083
176 LIVER FUNCTION TEST ABNORMAL 241 0.0083
177 ATAXIA 98 0.0082
178 ACUTE RESPIRATORY DISTRESS SYNDROME 145 0.0082
179 PARANOIA 141 0.0082
180 PANIC REACTION 59 0.0082
181 CYTOLYTIC HEPATITIS 27 0.0081
182 VARICOSE VEIN 42 0.0081
183 PSYCHOTIC DISORDER 240 0.0081
184 BREATH SOUNDS ABNORMAL 40 0.0081
185 ACUTE HEPATIC FAILURE 110 0.0080
186 CHROMATURIA 181 0.0080
187 LOGORRHOEA 28 0.0079
188 CUTANEOUS VASCULITIS 29 0.0079
189 EPIGASTRIC DISCOMFORT 31 0.0079
190 IRIDOCYCLITIS 25 0.0079
191 CONTRAINDICATED PRODUCT ADMINISTERED 239 0.0079
192 JAUNDICE 212 0.0079
193 CONJUNCTIVAL HYPERAEMIA 28 0.0078
194 ACIDOSIS 60 0.0078
195 THERAPEUTIC AGENT TOXICITY 26 0.0078
196 ANXIETY DISORDER 26 0.0078
197 ABORTION SPONTANEOUS 310 0.0077
198 GINGIVAL SWELLING 34 0.0077
199 DISSOCIATION 59 0.0077
200 BLOOD CREATINE INCREASED 34 0.0077
201 CANDIDA INFECTION 129 0.0076
202 HAEMOPTYSIS 213 0.0076
203 HEPATIC STEATOSIS 142 0.0076
204 DRUG-INDUCED LIVER INJURY 238 0.0076
205 OTITIS MEDIA 25 0.0076
206 MULTIPLE ORGAN DYSFUNCTION SYNDROME 212 0.0075
207 PSEUDOMONAS INFECTION 64 0.0075
208 HIATUS HERNIA 96 0.0074
209 SPUTUM DISCOLOURED 70 0.0074
210 AUTOIMMUNE HAEMOLYTIC ANAEMIA 25 0.0073
211 FACE OEDEMA 123 0.0073
212 CLOSTRIDIUM DIFFICILE INFECTION 159 0.0073
213 NIGHTMARE 249 0.0072
214 HEPATOCELLULAR INJURY 102 0.0072
215 NEPHRITIS 24 0.0072
216 CIRCULATORY COLLAPSE 121 0.0071
217 DISSEMINATED INTRAVASCULAR COAGULATION 100 0.0071
218 GASTRITIS EROSIVE 33 0.0071
219 OEDEMA MOUTH 23 0.0070
220 ASPERGILLUS INFECTION 46 0.0070
221 PETECHIAE 73 0.0070
222 DERMATITIS ALLERGIC 88 0.0070
223 DYSPHONIA 408 0.0070
224 PANIC DISORDER 27 0.0070
225 HEPATIC FUNCTION ABNORMAL 258 0.0069
226 BLOOD CREATINE PHOSPHOKINASE INCREASED 199 0.0069
227 AGRANULOCYTOSIS 128 0.0069
228 MOUTH ULCERATION 145 0.0069
229 COLITIS 260 0.0069
230 EMPHYSEMA 69 0.0068
231 HEPATOMEGALY 67 0.0068
232 TINNITUS 313 0.0068
233 HAEMORRHAGE SUBCUTANEOUS 24 0.0068
234 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 174 0.0068
235 HYPOGLYCAEMIA 327 0.0067
236 HALLUCINATION 508 0.0067
237 ACUTE KIDNEY INJURY 1031 0.0067
238 NEUTROPENIC SEPSIS 48 0.0067
239 OCULAR ICTERUS 29 0.0067
240 HALLUCINATION, VISUAL 141 0.0067
241 SENSITIVITY TO WEATHER CHANGE 35 0.0066
242 ENCEPHALITIS 46 0.0066
243 RESPIRATORY ACIDOSIS 26 0.0066
244 HALLUCINATION, AUDITORY 105 0.0066
245 NYSTAGMUS 35 0.0066
246 OBSTRUCTIVE AIRWAYS DISORDER 73 0.0066
247 MULTI-ORGAN FAILURE 113 0.0065
248 TEARFULNESS 28 0.0065
249 CARDIOMEGALY 80 0.0065
250 PRODUCTIVE COUGH 310 0.0065
251 EOSINOPHIL COUNT INCREASED 54 0.0065
252 HEPATITIS ACUTE 42 0.0065
253 MENINGITIS ASEPTIC 29 0.0065
254 CHOLESTASIS 124 0.0065
255 HYPOALBUMINAEMIA 50 0.0064
256 TRICUSPID VALVE INCOMPETENCE 51 0.0064
257 PULMONARY ALVEOLAR HAEMORRHAGE 36 0.0064
258 MYOCARDIAL ISCHAEMIA 73 0.0064
259 DIVERTICULUM INTESTINAL 28 0.0064
260 RECTAL HAEMORRHAGE 275 0.0064
261 DRUG TOXICITY 87 0.0064
262 URINE ABNORMALITY 29 0.0064
263 EUPHORIC MOOD 65 0.0063
264 HYPERKALAEMIA 220 0.0063
265 AMYLASE INCREASED 23 0.0062
266 IRON DEFICIENCY ANAEMIA 57 0.0062
267 EOSINOPHILIA 108 0.0062
268 LUNG INFILTRATION 54 0.0061
269 FIBROMYALGIA 148 0.0061
270 SUPRAVENTRICULAR TACHYCARDIA 58 0.0061
271 VENTRICULAR TACHYCARDIA 100 0.0060
272 ORGANISING PNEUMONIA 30 0.0060
273 PANCYTOPENIA 337 0.0060
274 DERMATITIS EXFOLIATIVE 30 0.0060
275 DELIRIUM 208 0.0060
276 PIGMENTATION DISORDER 37 0.0060
277 PAROSMIA 45 0.0060
278 TOXIC SKIN ERUPTION 60 0.0060
279 HAEMODIALYSIS 50 0.0059
280 NEUROLOGICAL SYMPTOM 34 0.0059
281 ODYNOPHAGIA 35 0.0059
282 CACHEXIA 30 0.0058
283 DUODENAL ULCER 41 0.0058
284 AZOTAEMIA 23 0.0058
285 TRANSAMINASES INCREASED 128 0.0058
286 LIVER DISORDER 255 0.0057
287 NECROSIS 32 0.0057
288 PNEUMOTHORAX 91 0.0057
289 AGITATION 418 0.0057
290 C-REACTIVE PROTEIN INCREASED 207 0.0057
291 IMMUNE THROMBOCYTOPENIA 26 0.0057
292 CHOLECYSTITIS CHRONIC 38 0.0057
293 DRUG LEVEL ABOVE THERAPEUTIC 26 0.0057
294 SLEEP APNOEA SYNDROME 108 0.0057
295 TRISMUS 29 0.0056
296 DRUG INTOLERANCE 542 0.0056
297 RESPIRATORY TRACT INFECTION 146 0.0056
298 HYPERURICAEMIA 23 0.0056
299 VEIN DISORDER 28 0.0056
300 PSYCHOMOTOR HYPERACTIVITY 92 0.0055
301 NEPHROTIC SYNDROME 38 0.0055
302 MEDICATION ERROR 307 0.0055
303 HAEMODYNAMIC INSTABILITY 42 0.0055
304 ELECTROLYTE IMBALANCE 64 0.0055
305 LIVER INJURY 135 0.0055
306 POLYURIA 45 0.0055
307 SUBCUTANEOUS ABSCESS 26 0.0054
308 HYPERTONIA 31 0.0054
309 ABSCESS LIMB 23 0.0054
310 PULMONARY TUBERCULOSIS 23 0.0054
311 HAEMATOCHEZIA 297 0.0054
312 RESPIRATORY FAILURE 392 0.0054
313 TONSILLITIS 28 0.0054
314 BONE MARROW FAILURE 109 0.0054
315 PHARYNGITIS 66 0.0053
316 MELAENA 117 0.0053
317 BLOOD ALKALINE PHOSPHATASE INCREASED 132 0.0053
318 TENDONITIS 82 0.0053
319 CHRONIC KIDNEY DISEASE 402 0.0053
320 PHARYNGEAL OEDEMA 81 0.0053
321 URINE OUTPUT DECREASED 46 0.0053
322 WHEEZING 312 0.0053
323 PULMONARY HAEMORRHAGE 41 0.0052
324 HYPERTHERMIA 40 0.0052
325 BUNDLE BRANCH BLOCK RIGHT 24 0.0052
326 VENTRICULAR FIBRILLATION 58 0.0052
327 END STAGE RENAL DISEASE 95 0.0052
328 RENAL IMPAIRMENT 436 0.0052
329 GAMMA-GLUTAMYLTRANSFERASE INCREASED 115 0.0052
330 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 284 0.0052
331 RASH VESICULAR 25 0.0052
332 PHOTOSENSITIVITY REACTION 85 0.0051
333 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26 0.0051
334 HAEMOLYTIC ANAEMIA 46 0.0051
335 HICCUPS 42 0.0051
336 HYPERBILIRUBINAEMIA 53 0.0051
337 COVID-19 PNEUMONIA 60 0.0051
338 ATRIOVENTRICULAR BLOCK COMPLETE 34 0.0051
339 STAPHYLOCOCCAL SEPSIS 25 0.0051
340 PNEUMONITIS 137 0.0050
341 POLYNEUROPATHY 60 0.0050
342 CHEILITIS 27 0.0050
343 DYSPEPSIA 490 0.0050
344 DISORIENTATION 197 0.0050
345 DELUSION 77 0.0050
346 LUNG INFECTION 77 0.0050
347 HYPERTRIGLYCERIDAEMIA 29 0.0049
348 UPPER GASTROINTESTINAL HAEMORRHAGE 83 0.0049
349 PALPITATIONS 576 0.0049
350 CONFUSIONAL STATE 794 0.0049
351 ORAL DISORDER 36 0.0049
352 NEUROLEPTIC MALIGNANT SYNDROME 58 0.0049
353 NEUTROPHIL COUNT INCREASED 50 0.0049
354 PLEURAL EFFUSION 296 0.0049
355 BRONCHITIS 360 0.0049
356 NEUROTOXICITY 85 0.0048
357 ANAPHYLACTIC REACTION 268 0.0048
358 ENTEROCOLITIS 28 0.0048
359 PROTHROMBIN TIME PROLONGED 29 0.0048
360 OLIGURIA 30 0.0048
361 RESPIRATORY DEPRESSION 59 0.0048
362 LYMPHOPENIA 68 0.0048
363 PYREXIA 1657 0.0048
364 RENAL CYST 38 0.0048
365 LOW BIRTH WEIGHT BABY 38 0.0048
366 DEAFNESS 125 0.0048
367 ALANINE AMINOTRANSFERASE INCREASED 293 0.0048
368 ATELECTASIS 46 0.0048
369 GUILLAIN-BARRE SYNDROME 23 0.0048
370 GOUT 85 0.0047
371 VASCULITIS 55 0.0047
372 COLITIS ULCERATIVE 211 0.0047
373 HYPOXIA 166 0.0047
374 TACHYPNOEA 64 0.0047
375 ENDOCARDITIS 24 0.0047
376 COLD SWEAT 82 0.0046
377 PANIC ATTACK 169 0.0046
378 SHOCK 106 0.0046
379 DIARRHOEA HAEMORRHAGIC 43 0.0046
380 HYPOMAGNESAEMIA 64 0.0046
381 BRADYPHRENIA 30 0.0046
382 SEASONAL ALLERGY 65 0.0046
383 BLOOD BILIRUBIN INCREASED 124 0.0046
384 THROAT TIGHTNESS 124 0.0046
385 ANOREXIA 59 0.0046
386 PRURITUS GENERALISED 99 0.0046
387 ANOSMIA 66 0.0046
388 PLEURISY 27 0.0045
389 INTERVERTEBRAL DISC DEGENERATION 42 0.0045
390 HYPERSENSITIVITY 842 0.0045
391 APPETITE DISORDER 30 0.0045
392 PULMONARY TOXICITY 32 0.0045
393 PNEUMONIA ASPIRATION 113 0.0045
394 CYSTITIS 144 0.0045
395 ABDOMINAL PAIN 1052 0.0045
396 RASH GENERALISED 117 0.0045
397 ABNORMAL FAECES 37 0.0045
398 DYSPNOEA EXERTIONAL 170 0.0045
399 HEPATOTOXICITY 100 0.0045
400 DYSARTHRIA 169 0.0045
401 HYPERVENTILATION 26 0.0045
402 BLOOD LACTATE DEHYDROGENASE INCREASED 71 0.0045
403 BACTERAEMIA 53 0.0045
404 MULTIPLE ALLERGIES 35 0.0045
405 HYPONATRAEMIA 251 0.0045
406 INFUSION SITE SWELLING 28 0.0044
407 RENAL PAIN 47 0.0044
408 ASCITES 130 0.0044
409 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 314 0.0044
410 GASTRITIS 116 0.0044
411 INTERSTITIAL LUNG DISEASE 213 0.0044
412 TASTE DISORDER 89 0.0044
413 RENAL TUBULAR NECROSIS 43 0.0044
414 LARYNGEAL OEDEMA 27 0.0044
415 WHITE BLOOD CELL COUNT INCREASED 168 0.0044
416 TENDON PAIN 33 0.0044
417 DEAFNESS UNILATERAL 24 0.0044
418 GENERALISED TONIC-CLONIC SEIZURE 72 0.0043
419 POOR QUALITY SLEEP 93 0.0043
420 OROPHARYNGEAL DISCOMFORT 39 0.0043
421 PERSONALITY CHANGE 40 0.0043
422 SKIN LESION 118 0.0043
423 BLOOD ALBUMIN DECREASED 34 0.0043
424 BRONCHOSPASM 61 0.0043
425 DEPRESSED LEVEL OF CONSCIOUSNESS 169 0.0043
426 FEELING OF BODY TEMPERATURE CHANGE 25 0.0043
427 THROMBOCYTOPENIA 476 0.0043
428 LEUKOCYTOSIS 77 0.0043
429 VENTRICULAR EXTRASYSTOLES 44 0.0042
430 PANCREATITIS ACUTE 95 0.0042
431 METABOLIC ACIDOSIS 135 0.0042
432 HAEMATEMESIS 107 0.0042
433 BRADYCARDIA 223 0.0042
434 GENERALISED OEDEMA 52 0.0042
435 CHOLANGITIS 26 0.0042
436 ECONOMIC PROBLEM 63 0.0042
437 ERYTHEMA 853 0.0041
438 RASH MACULAR 144 0.0041
439 PAPULE 29 0.0041
440 SEROTONIN SYNDROME 79 0.0041
441 GASTROENTERITIS 60 0.0041
442 LYMPHADENOPATHY 145 0.0041
443 CYANOSIS 64 0.0041
444 ENERGY INCREASED 24 0.0041
445 HYPERCALCAEMIA 50 0.0040
446 HYSTERECTOMY 35 0.0040
447 RASH ERYTHEMATOUS 193 0.0040
448 HEPATITIS 103 0.0040
449 DIZZINESS POSTURAL 39 0.0040
450 HYPOKALAEMIA 185 0.0040
451 ABDOMINAL PAIN UPPER 819 0.0040
452 OPTIC NEURITIS 36 0.0040
453 TACHYCARDIA 351 0.0039
454 ANURIA 34 0.0039
455 HEPATIC FAILURE 119 0.0039
456 RESPIRATORY RATE INCREASED 35 0.0039
457 PNEUMONIA 1264 0.0039
458 VITAMIN D DEFICIENCY 38 0.0039
459 RENAL FAILURE 517 0.0039
460 ORAL HERPES 76 0.0039
461 INFUSION RELATED REACTION 258 0.0039
462 MALAISE 1707 0.0039
463 BLOOD CREATININE INCREASED 254 0.0039
464 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
465 FAECES DISCOLOURED 84 0.0039
466 CHOLECYSTITIS 46 0.0039
467 PULMONARY FIBROSIS 74 0.0039
468 ENCEPHALOPATHY 94 0.0038
469 RESTLESSNESS 140 0.0038
470 MOUTH HAEMORRHAGE 28 0.0038
471 GINGIVAL BLEEDING 52 0.0038
472 AGEUSIA 94 0.0038
473 SKIN REACTION 53 0.0038
474 IMMUNODEFICIENCY 56 0.0038
475 SEPTIC SHOCK 163 0.0037
476 TENDON RUPTURE 46 0.0037
477 RHINITIS 30 0.0037
478 RESPIRATORY DISORDER 111 0.0037
479 ANAEMIA 707 0.0037
480 FACIAL PAIN 33 0.0037
481 PNEUMOCYSTIS JIROVECII PNEUMONIA 37 0.0037
482 UNRESPONSIVE TO STIMULI 95 0.0037
483 ABNORMAL LOSS OF WEIGHT 25 0.0037
484 ASTHMA 414 0.0037
485 ORAL PAIN 82 0.0037
486 RASH PAPULAR 82 0.0037
487 ESCHERICHIA INFECTION 30 0.0036
488 BACTERIAL INFECTION 68 0.0036
489 SPINAL OSTEOARTHRITIS 32 0.0036
490 ABDOMINAL PAIN LOWER 92 0.0036
491 ABSCESS 58 0.0036
492 RASH PRURITIC 197 0.0036
493 ADRENAL INSUFFICIENCY 44 0.0036
494 ASPARTATE AMINOTRANSFERASE INCREASED 192 0.0036
495 VERTIGO 220 0.0036
496 HEPATIC CYTOLYSIS 46 0.0036
497 EAR DISCOMFORT 37 0.0036
498 ORAL DISCOMFORT 50 0.0036
499 THINKING ABNORMAL 67 0.0036
500 DYSPNOEA 2033 0.0036
501 CARDIAC ARREST 296 0.0036
502 ABNORMAL BEHAVIOUR 142 0.0036
503 CARDIAC MURMUR 31 0.0036
504 BODY TEMPERATURE INCREASED 73 0.0036
505 ANHEDONIA 94 0.0036
506 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
507 PHOTOPHOBIA 67 0.0036
508 URTICARIA 594 0.0035
509 DRUG LEVEL DECREASED 36 0.0035
510 PSYCHIATRIC SYMPTOM 26 0.0035
511 HYPERCHOLESTEROLAEMIA 34 0.0035
512 ALTERED STATE OF CONSCIOUSNESS 76 0.0035
513 OEDEMA PERIPHERAL 427 0.0035
514 HAEMOLYSIS 27 0.0035
515 FEAR 94 0.0035
516 COUGH 979 0.0035
517 HAEMATURIA 119 0.0035
518 DISEASE RECURRENCE 165 0.0035
519 APNOEA 27 0.0035
520 RENAL INJURY 103 0.0035
521 UVEITIS 47 0.0035
522 CARDIAC FAILURE ACUTE 23 0.0034
523 MENINGITIS 23 0.0034
524 AFFECTIVE DISORDER 27 0.0034
525 MUSCLE TWITCHING 79 0.0034
526 JOINT DISLOCATION 36 0.0034
527 IMMUNOSUPPRESSION 30 0.0034
528 CONJUNCTIVITIS 63 0.0034
529 SEPSIS 378 0.0034
530 RENAL FAILURE CHRONIC 26 0.0034
531 ARRHYTHMIA 160 0.0034
532 EYELID OEDEMA 39 0.0034
533 BLOOD UREA INCREASED 56 0.0033
534 CELLULITIS 168 0.0033
535 CHEST DISCOMFORT 341 0.0033
536 ANXIETY 946 0.0033
537 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
538 BIPOLAR DISORDER 36 0.0033
539 DIPLOPIA 86 0.0033
540 HEART RATE INCREASED 328 0.0033
541 HYPERTRANSAMINASAEMIA 23 0.0033
542 RASH PUSTULAR 24 0.0033
543 ABORTION INDUCED 31 0.0033
544 PULMONARY MASS 49 0.0033
545 TOXICITY TO VARIOUS AGENTS 552 0.0033
546 MUSCLE RIGIDITY 39 0.0033
547 NIGHT SWEATS 105 0.0033
548 BLISTER 183 0.0033
549 SINUSITIS 332 0.0032
550 MICTURITION URGENCY 37 0.0032
551 HYPERHIDROSIS 417 0.0032
552 VOMITING 1518 0.0032
553 AKATHISIA 44 0.0032
554 ABNORMAL DREAMS 89 0.0032
555 INSOMNIA 852 0.0032
556 ASPIRATION 35 0.0032
557 TUMOUR LYSIS SYNDROME 28 0.0032
558 HYPERLIPIDAEMIA 38 0.0032
559 THERAPEUTIC PRODUCT EFFECT DECREASED 142 0.0032
560 DERMATITIS CONTACT 36 0.0032
561 SCAB 36 0.0032
562 ERUCTATION 61 0.0031
563 DYSURIA 116 0.0031
564 TREMOR 519 0.0031
565 SKIN INFECTION 35 0.0031
566 ACUTE RESPIRATORY FAILURE 60 0.0031
567 HYPOAESTHESIA ORAL 47 0.0031
568 AFFECT LABILITY 30 0.0031
569 DIARRHOEA 2011 0.0031
570 OSTEOARTHRITIS 132 0.0031
571 NEPHROPATHY 29 0.0031
572 MUSCULAR WEAKNESS 353 0.0031
573 GASTRIC ULCER 59 0.0031
574 SALIVARY HYPERSECRETION 31 0.0031
575 SENSATION OF FOREIGN BODY 26 0.0031
576 OEDEMA 167 0.0031
577 LEUKOPENIA 154 0.0031
578 THIRST 55 0.0031
579 PLASMA CELL MYELOMA 120 0.0031
580 SPLENOMEGALY 36 0.0031
581 PERICARDIAL EFFUSION 71 0.0031
582 HYPOCALCAEMIA 58 0.0031
583 HYPOTHERMIA 31 0.0031
584 PERIPHERAL COLDNESS 42 0.0031
585 DYSPHAGIA 289 0.0030
586 EXPOSURE DURING PREGNANCY 187 0.0030
587 LETHARGY 173 0.0030
588 ANAL INCONTINENCE 27 0.0030
589 GASTRIC DISORDER 103 0.0030
590 HEPATIC ENCEPHALOPATHY 28 0.0030
591 FUNGAL INFECTION 100 0.0030
592 MYALGIA 510 0.0030
593 MUSCLE ATROPHY 38 0.0030
594 GASTROOESOPHAGEAL REFLUX DISEASE 241 0.0030
595 PLATELET COUNT INCREASED 39 0.0030
596 MIOSIS 24 0.0030
597 CARDIAC FAILURE 240 0.0030
598 OROPHARYNGEAL PAIN 276 0.0030
599 RESPIRATORY DISTRESS 82 0.0030
600 BLOOD SODIUM DECREASED 56 0.0030
601 DRY MOUTH 241 0.0030
602 TREATMENT FAILURE 246 0.0030
603 EAR INFECTION 79 0.0030
604 RASH 1292 0.0030
605 SLEEP DISORDER 209 0.0030
606 RESPIRATORY TRACT CONGESTION 47 0.0030
607 SPINAL DISORDER 28 0.0030
608 THROAT IRRITATION 132 0.0029
609 LYMPHOCYTE COUNT DECREASED 52 0.0029
610 STOMATITIS 178 0.0029
611 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
612 LIGAMENT SPRAIN 29 0.0029
613 GLOMERULAR FILTRATION RATE DECREASED 36 0.0029
614 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30 0.0029
615 NAUSEA 2311 0.0029
616 PRODUCT PRESCRIBING ERROR 69 0.0029
617 OSTEOPOROSIS 119 0.0029
618 SINUS TACHYCARDIA 41 0.0029
619 PULMONARY CONGESTION 38 0.0029
620 PRESYNCOPE 70 0.0029
621 PALLOR 78 0.0029
622 INFLAMMATION 147 0.0028
623 EPILEPSY 87 0.0028
624 BODY TEMPERATURE DECREASED 28 0.0028
625 NEUROPATHY PERIPHERAL 270 0.0028
626 UPPER RESPIRATORY TRACT INFECTION 131 0.0028
627 CYTOMEGALOVIRUS INFECTION 47 0.0028
628 OBESITY 45 0.0028
629 GRAND MAL CONVULSION 26 0.0028
630 APATHY 41 0.0028
631 MENTAL DISORDER 122 0.0028
632 WEIGHT DECREASED 782 0.0028
633 ACUTE CORONARY SYNDROME 23 0.0028
634 HEPATIC ENZYME INCREASED 189 0.0028
635 EYE SWELLING 103 0.0028
636 MENTAL IMPAIRMENT 67 0.0028
637 COELIAC DISEASE 27 0.0027
638 CONVULSION 157 0.0027
639 URINARY RETENTION 91 0.0027
640 EAR PAIN 53 0.0027
641 RETCHING 58 0.0027
642 SECRETION DISCHARGE 34 0.0027
643 BLOOD POTASSIUM INCREASED 44 0.0027
644 GASTROINTESTINAL HAEMORRHAGE 226 0.0027
645 ORTHOSTATIC HYPOTENSION 47 0.0027
646 FLUID RETENTION 137 0.0027
647 TENDERNESS 28 0.0027
648 PULMONARY EMBOLISM 255 0.0027
649 PROTEINURIA 51 0.0027
650 ABDOMINAL DISTENSION 280 0.0027
651 DIVERTICULITIS 74 0.0027
652 DEPRESSED MOOD 141 0.0027
653 SYNCOPE 266 0.0027
654 AGGRESSION 133 0.0027
655 GASTROINTESTINAL DISORDER 238 0.0027
656 STATUS EPILEPTICUS 30 0.0027
657 HEART RATE IRREGULAR 60 0.0027
658 OSTEOMYELITIS 48 0.0026
659 SUBARACHNOID HAEMORRHAGE 27 0.0026
660 PANCREATITIS 140 0.0026
661 CHEST PAIN 488 0.0026
662 BLOOD PRESSURE DECREASED 175 0.0026
663 NASAL CONGESTION 154 0.0026
664 HEADACHE 1641 0.0026
665 SENSORY DISTURBANCE 42 0.0026
666 CYTOPENIA 32 0.0026
667 MIGRAINE 249 0.0026
668 KIDNEY INFECTION 51 0.0026
669 SWELLING 243 0.0026
670 DISTURBANCE IN ATTENTION 140 0.0026
671 APHONIA 36 0.0026
672 CARDIOGENIC SHOCK 37 0.0026
673 ULCER 41 0.0026
674 EJECTION FRACTION DECREASED 40 0.0026
675 IMPAIRED QUALITY OF LIFE 37 0.0026
676 URINARY INCONTINENCE 76 0.0026
677 PREMATURE BABY 77 0.0026
678 INCONTINENCE 27 0.0026
679 CONDITION AGGRAVATED 776 0.0025
680 NEUTROPENIA 347 0.0025
681 ABDOMINAL DISCOMFORT 426 0.0025
682 MUCOSAL INFLAMMATION 66 0.0025
683 NERVE INJURY 28 0.0025
684 SINUS CONGESTION 34 0.0025
685 COORDINATION ABNORMAL 35 0.0025
686 GLOSSODYNIA 56 0.0025
687 EPISTAXIS 187 0.0025
688 POST PROCEDURAL HAEMORRHAGE 29 0.0025
689 RENAL DISORDER 116 0.0025
690 DIZZINESS 1240 0.0025
691 ECZEMA 130 0.0025
692 SPINAL PAIN 29 0.0025
693 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 129 0.0025
694 HAEMATOMA 64 0.0025
695 ATRIAL FIBRILLATION 240 0.0025
696 NO THERAPEUTIC RESPONSE 30 0.0025
697 HYPOTENSION 493 0.0025
698 SNEEZING 55 0.0024
699 LUNG DISORDER 120 0.0024
700 BALANCE DISORDER 211 0.0024
701 VIRAL INFECTION 81 0.0024
702 HEAD DISCOMFORT 43 0.0024
703 MOOD SWINGS 77 0.0024
704 SEDATION 63 0.0024
705 CAESAREAN SECTION 28 0.0024
706 OXYGEN SATURATION DECREASED 135 0.0024
707 SKIN ULCER 62 0.0024
708 STAPHYLOCOCCAL INFECTION 79 0.0024
709 HYPERGLYCAEMIA 87 0.0024
710 SPEECH DISORDER 125 0.0024
711 MITRAL VALVE INCOMPETENCE 27 0.0024
712 FEELING HOT 146 0.0024
713 CARDIAC FAILURE CONGESTIVE 191 0.0024
714 ACUTE MYOCARDIAL INFARCTION 70 0.0024
715 CEREBRAL INFARCTION 58 0.0024
716 BLOOD GLUCOSE FLUCTUATION 26 0.0024
717 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
718 MATERNAL EXPOSURE DURING PREGNANCY 211 0.0024
719 HAND DEFORMITY 31 0.0024
720 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
721 PRURITUS 904 0.0023
722 MUSCLE TIGHTNESS 38 0.0023
723 ILEUS 29 0.0023
724 INTENTIONAL SELF-INJURY 47 0.0023
725 PREMATURE DELIVERY 37 0.0023
726 DEHYDRATION 308 0.0023
727 PLATELET COUNT DECREASED 246 0.0023
728 OSTEOPENIA 35 0.0023
729 ANGINA PECTORIS 66 0.0023
730 VISION BLURRED 316 0.0023
731 BRAIN OEDEMA 29 0.0023
732 INFLUENZA 254 0.0023
733 HYPOACUSIS 98 0.0023
734 NEUTROPHIL COUNT DECREASED 92 0.0023
735 URINARY TRACT INFECTION 385 0.0023
736 DECREASED APPETITE 524 0.0023
737 GALLBLADDER DISORDER 40 0.0022
738 DEPRESSION 509 0.0022
739 BRAIN FOG 35 0.0022
740 CRYING 81 0.0022
741 BLOOD CALCIUM DECREASED 25 0.0022
742 LACTIC ACIDOSIS 72 0.0022
743 CONTUSION 214 0.0022
744 NEURALGIA 54 0.0022
745 HYPOKINESIA 32 0.0022
746 THERAPY NON-RESPONDER 99 0.0022
747 HERPES ZOSTER 126 0.0022
748 HAEMOGLOBIN DECREASED 225 0.0022
749 APHASIA 66 0.0022
750 SOMNOLENCE 440 0.0022
751 SKIN EXFOLIATION 184 0.0022
752 LOSS OF CONSCIOUSNESS 276 0.0022
753 CHILLS 252 0.0021
754 RESTLESS LEGS SYNDROME 39 0.0021
755 BURSITIS 26 0.0021
756 ILLNESS 220 0.0021
757 CONSTIPATION 465 0.0021
758 EYE INFECTION 24 0.0021
759 IMMUNE SYSTEM DISORDER 28 0.0021
760 PULMONARY HYPERTENSION 44 0.0021
761 PARAESTHESIA 332 0.0021
762 PRODUCT USE IN UNAPPROVED INDICATION 523 0.0021
763 GENERAL PHYSICAL HEALTH DETERIORATION 244 0.0021
764 LOCALISED INFECTION 51 0.0021
765 MYOCLONUS 25 0.0021
766 DYSKINESIA 85 0.0021
767 RIB FRACTURE 43 0.0021
768 FEELING COLD 58 0.0021
769 BACK PAIN 484 0.0021
770 HYPERTENSION 438 0.0021
771 RHINORRHOEA 133 0.0021
772 MALNUTRITION 23 0.0021
773 IMPAIRED GASTRIC EMPTYING 28 0.0021
774 DISEASE PROGRESSION 243 0.0021
775 MOOD ALTERED 56 0.0021
776 DEEP VEIN THROMBOSIS 133 0.0020
777 OCULAR HYPERAEMIA 97 0.0020
778 PULMONARY OEDEMA 91 0.0020
779 DRUG PRESCRIBING ERROR 39 0.0020
780 BLOOD POTASSIUM DECREASED 61 0.0020
781 ASTHENIA 758 0.0020
782 CHOLELITHIASIS 66 0.0020
783 HYPOTHYROIDISM 64 0.0020
784 MUSCULOSKELETAL CHEST PAIN 31 0.0020
785 SUICIDAL IDEATION 183 0.0020
786 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 96 0.0020
787 MOVEMENT DISORDER 64 0.0020
788 FLUID OVERLOAD 29 0.0020
789 DRUG INEFFECTIVE 2623 0.0020
790 HYPERSOMNIA 57 0.0020
791 BURNING SENSATION 138 0.0020
792 HAEMATOCRIT DECREASED 39 0.0020
793 MUSCULOSKELETAL STIFFNESS 172 0.0020
794 DYSTONIA 38 0.0020
795 WHITE BLOOD CELL COUNT DECREASED 211 0.0019
796 EYE DISORDER 64 0.0019
797 FEELING ABNORMAL 466 0.0019
798 HUNGER 27 0.0019
799 NASOPHARYNGITIS 357 0.0019
800 HYPOPHAGIA 49 0.0019
801 HAEMORRHOIDS 37 0.0019
802 OFF LABEL USE 1659 0.0019
803 LOCAL SWELLING 33 0.0019
804 SKIN DISORDER 63 0.0019
805 DEVICE RELATED INFECTION 29 0.0019
806 COMA 89 0.0019
807 CARDIO-RESPIRATORY ARREST 78 0.0019
808 LIVER FUNCTION TEST INCREASED 40 0.0019
809 INFUSION SITE PAIN 24 0.0019
810 DERMATITIS 39 0.0019
811 THERAPY PARTIAL RESPONDER 29 0.0019
812 NEPHROLITHIASIS 85 0.0019
813 INFECTION 268 0.0018
814 RESPIRATORY ARREST 51 0.0018
815 PERIPHERAL SWELLING 283 0.0018
816 SEIZURE 212 0.0018
817 POISONING 23 0.0018
818 CARDIOMYOPATHY 27 0.0018
819 ARTHRALGIA 759 0.0018
820 IRRITABILITY 109 0.0018
821 LYMPHOMA 28 0.0018
822 BLOOD TRIGLYCERIDES INCREASED 32 0.0018
823 PAIN IN JAW 51 0.0018
824 AMNESIA 117 0.0018
825 MYDRIASIS 23 0.0018
826 QUALITY OF LIFE DECREASED 24 0.0018
827 MUSCULOSKELETAL PAIN 93 0.0018
828 FLATULENCE 100 0.0018
829 HYPOAESTHESIA 260 0.0017
830 COGNITIVE DISORDER 81 0.0017
831 JOINT STIFFNESS 45 0.0017
832 CARPAL TUNNEL SYNDROME 24 0.0017
833 PRODUCT TASTE ABNORMAL 23 0.0017
834 INTERVERTEBRAL DISC PROTRUSION 37 0.0017
835 FOOT FRACTURE 32 0.0017
836 BLOOD PRESSURE INCREASED 258 0.0017
837 FEEDING DISORDER 34 0.0017
838 FOETAL EXPOSURE DURING PREGNANCY 136 0.0017
839 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
840 PAIN IN EXTREMITY 491 0.0017
841 EYE PAIN 94 0.0017
842 MENTAL STATUS CHANGES 46 0.0017
843 EMOTIONAL DISORDER 51 0.0017
844 PAIN 1014 0.0016
845 ADVERSE DRUG REACTION 148 0.0016
846 NERVOUSNESS 86 0.0016
847 MUSCLE SPASMS 300 0.0016
848 BLOOD URINE PRESENT 31 0.0016
849 MUSCULOSKELETAL DISCOMFORT 28 0.0016
850 HEART RATE DECREASED 57 0.0016
851 DISCOMFORT 99 0.0016
852 SINUS DISORDER 32 0.0016
853 CARDIOVASCULAR DISORDER 41 0.0016
854 TREATMENT NONCOMPLIANCE 88 0.0016
855 POLLAKIURIA 67 0.0016
856 ARTHRITIS 125 0.0016
857 DRUG EXPOSURE DURING PREGNANCY 54 0.0016
858 IRRITABLE BOWEL SYNDROME 34 0.0016
859 CORONARY ARTERY DISEASE 48 0.0016
860 VISUAL IMPAIRMENT 194 0.0016
861 FATIGUE 1214 0.0016
862 GASTROENTERITIS VIRAL 28 0.0015
863 PERICARDITIS 26 0.0015
864 PERITONITIS 32 0.0015
865 GAIT DISTURBANCE 295 0.0015
866 SKIN DISCOLOURATION 70 0.0015
867 DIABETES MELLITUS 116 0.0015
868 CEREBRAL HAEMORRHAGE 54 0.0015
869 JOINT SWELLING 182 0.0015
870 BLOOD PRESSURE FLUCTUATION 36 0.0015
871 ABASIA 37 0.0015
872 LIMB DISCOMFORT 46 0.0015
873 DRY EYE 73 0.0015
874 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
875 NERVOUS SYSTEM DISORDER 45 0.0014
876 FALL 473 0.0014
877 OESOPHAGEAL CARCINOMA 42 0.0014
878 VISUAL ACUITY REDUCED 47 0.0014
879 SCAR 24 0.0014
880 INJURY 98 0.0014
881 HEAD INJURY 44 0.0014
882 EMOTIONAL DISTRESS 168 0.0014
883 HEMIPARESIS 23 0.0014
884 ANAPHYLACTIC SHOCK 35 0.0014
885 COVID-19 238 0.0014
886 HERNIA 26 0.0013
887 EXTRAPYRAMIDAL DISORDER 33 0.0013
888 TOOTHACHE 24 0.0013
889 SUICIDE ATTEMPT 80 0.0013
890 FEBRILE NEUTROPENIA 86 0.0013
891 NECK PAIN 72 0.0013
892 ACCIDENTAL OVERDOSE 47 0.0013
893 CHOKING 25 0.0013
894 HEPATIC CIRRHOSIS 24 0.0013
895 PAIN OF SKIN 34 0.0013
896 HAEMORRHAGE 132 0.0013
897 BLOOD GLUCOSE DECREASED 60 0.0012
898 MOBILITY DECREASED 89 0.0012
899 DYSSTASIA 36 0.0012
900 MIDDLE INSOMNIA 23 0.0012
901 EATING DISORDER 26 0.0012
902 WEIGHT INCREASED 273 0.0012
903 OSTEONECROSIS OF JAW 30 0.0012
904 INTENTIONAL PRODUCT USE ISSUE 106 0.0012
905 ERECTILE DYSFUNCTION 31 0.0012
906 INCREASED APPETITE 23 0.0012
907 THROMBOSIS 96 0.0012
908 FULL BLOOD COUNT DECREASED 24 0.0012
909 RED BLOOD CELL COUNT DECREASED 34 0.0012
910 PRESCRIBED OVERDOSE 23 0.0012
911 BONE DENSITY DECREASED 37 0.0012
912 IMPAIRED HEALING 38 0.0012
913 THERAPEUTIC RESPONSE DECREASED 70 0.0012
914 INFLUENZA LIKE ILLNESS 94 0.0011
915 CATARACT 68 0.0011
916 INTENTIONAL OVERDOSE 73 0.0011
917 IMPAIRED WORK ABILITY 24 0.0011
918 PRODUCT USE ISSUE 209 0.0011
919 MEMORY IMPAIRMENT 152 0.0011
920 GASTRIC CANCER 28 0.0011
921 BLINDNESS 45 0.0011
922 ILL-DEFINED DISORDER 67 0.0011
923 TARDIVE DYSKINESIA 31 0.0011
924 ARTHROPATHY 60 0.0011
925 BONE PAIN 62 0.0011
926 ANGER 35 0.0010
927 EYE IRRITATION 59 0.0010
928 MYOCARDIAL INFARCTION 178 0.0010
929 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
930 WOUND 28 0.0010
931 INCORRECT DRUG ADMINISTRATION DURATION 28 0.0010
932 BLOOD CHOLESTEROL INCREASED 46 0.0010
933 MYELOSUPPRESSION 35 0.0010
934 GAIT INABILITY 32 0.0010
935 LIMB INJURY 26 0.0010
936 LACRIMATION INCREASED 28 0.0009
937 VAGINAL HAEMORRHAGE 40 0.0009
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 166 0.0009
939 TYPE 2 DIABETES MELLITUS 31 0.0009
940 WITHDRAWAL SYNDROME 38 0.0009
941 OVERDOSE 195 0.0009
942 EYE PRURITUS 30 0.0009
943 PSORIATIC ARTHROPATHY 36 0.0009
944 UNEVALUABLE EVENT 64 0.0008
945 INTENTIONAL DOSE OMISSION 24 0.0008
946 INJECTION SITE BRUISING 66 0.0008
947 OSTEONECROSIS 27 0.0008
948 PRODUCT DOSE OMISSION ISSUE 241 0.0008
949 FLUSHING 83 0.0008
950 SYSTEMIC LUPUS ERYTHEMATOSUS 28 0.0008
951 SURGERY 46 0.0008
952 HOT FLUSH 59 0.0008
953 LABORATORY TEST ABNORMAL 23 0.0008
954 RHEUMATOID ARTHRITIS 88 0.0008
955 ALOPECIA 152 0.0008
956 INTENTIONAL PRODUCT MISUSE 67 0.0008
957 DRUG ABUSE 63 0.0008
958 LUNG NEOPLASM MALIGNANT 31 0.0008
959 CEREBROVASCULAR ACCIDENT 123 0.0007
960 ROAD TRAFFIC ACCIDENT 30 0.0007
961 INTESTINAL OBSTRUCTION 27 0.0007
962 UNDERDOSE 52 0.0007
963 DRY SKIN 94 0.0007
964 DERMATITIS ATOPIC 37 0.0007
965 THERAPY INTERRUPTED 49 0.0007
966 ACNE 49 0.0006
967 DRUG EFFECT INCOMPLETE 23 0.0006
968 SKIN BURNING SENSATION 45 0.0006
969 HOSPITALISATION 95 0.0006
970 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
971 INCORRECT DOSE ADMINISTERED 131 0.0006
972 PRODUCT SUBSTITUTION ISSUE 31 0.0005
973 CARDIAC DISORDER 49 0.0005
974 INJECTION SITE REACTION 36 0.0005
975 BLOOD GLUCOSE INCREASED 97 0.0005
976 DRUG EFFECT DECREASED 27 0.0005
977 ADVERSE EVENT 44 0.0005
978 NEOPLASM MALIGNANT 28 0.0004
979 INJECTION SITE PRURITUS 27 0.0004
980 PSORIASIS 51 0.0004
981 INJECTION SITE SWELLING 29 0.0004
982 DEATH 309 0.0004
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
984 COMPLETED SUICIDE 26 0.0003
985 INJECTION SITE PAIN 92 0.0003
986 DRUG DEPENDENCE 48 0.0003
987 INJECTION SITE ERYTHEMA 37 0.0003
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
989 DRUG DOSE OMISSION 45 0.0003
990 PRODUCT QUALITY ISSUE 28 0.0002
991 NO ADVERSE EVENT 33 0.0002